TMCnet News

Research and Markets: Inhaled Drug Delivery Seminar: London, UK - 5-6th November 2014
[September 24, 2014]

Research and Markets: Inhaled Drug Delivery Seminar: London, UK - 5-6th November 2014


DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/btpdfh/inhaled_drug) has announced the addition of the "Inhaled Drug Delivery (London, UK)" conference to their offering.

Conference Date: 05-06 Nov 2014

Venue: The Rembrandt Hotel, London

BENEFITS IN ATTENDING:

- Hear the latest on market trends and opportunities

- Gain an update on new technologies and developments

- Understand new therapeutic fields for inhalation drug delivery

- Keep abreast of new regulatory updates

- Technology showcase for many companies

- Excellent networking opportunity

Key Topics Covered:

Day One

09.30 - Chairman's Welcome and Introduction

Dr Steve Nichols, OINDP Specialist Consultant, UK

KEY NOTE ADDRESS

09.40 - COPD: New Drug Developments

Professor Peter Barnes, Professor of Thoracic Medicine and Head of Respiratory Medicine, National Heart and Lung Institute, UK

10.20 - Is it the End of the Road for MDIs?

Dr Tim Noakes, Mexichem Fluor, UK

11.00 - Discussion followed by Coffee

11.30 - Can we Improve the Way we Perform Clinical Trials?

Dr John Pritchard, Chief Technology Officer for Respiratory Drug Delivery, Philips (News - Alert) Healthcare

12.10 - ASAP: Method of Determining Stability in Products - Using Science o Set Shelf Life



Piero De Filippis, Stability Team Manager, Aptuit, Italy (invited)

12.50 - Discussion followed by Lunch


PRODUCT APPROVALS

14.00 - Parallel Multiple Drug and Device Development - A Challenge too Far?

Andrew Grant, Andrew Grant Associates, UK (invited)

14.40 - Afrezza® Inhaled Insulin - The Development of a Dry Powder Orally Inhaled Insulin Product

Dr Andrea Leone-Bay, Vice President Pharmaceutical Research, MannKind Corp, USA

15.20 - Discussion followed by Tea

FORMULATION

16.00 - Understanding Formulation Device Interactions - How Much can we Measure and Predict?

Frank Thielmann, Operational Lead Inhalation New Solids, Novartis Pharma AG, Switzerland

NOVEL INHALATION THERAPY - BIOLOGICALS

16.40 - Development of Inhaled Interferon Beta for the Prevention or Attenuation of Virus Induced Asthma Exacerbations

Phillip Monk, Chief Scientific Officer, Synairgen Research Ltd, UK

17.20 - Discussion

17.30 - End of Day One

17.30 - Networking Drinks Reception for Delegates and Speakers

Day Two

09.15 - Chairman's Review of Day One

Dr Ian Smith, Director H12 Consulting, UK

EMERGING MARKETS

9.30 - The Marketing Analytics of Inhalation Products for Asthma COPD in China

Dr Anny Shen, Managing Director Bering Scientific Information Ltd. and Chairman of the Inhalation Drug Delivery Association, China

NON-CLINICAL TESTING

10.10 - Twenty Critical Questions you Must ask When Planning to Dose by the Inhaled Route

Dr Simon Moore, Head of Aerosol Technology, Huntingdon Life Sciences, UK

10.50 - Discussion

11.00 - Coffee

FORMULATION

11.30 - Inhalation Strategies to Treat Respiratory Infections

Dr. Hui Xin Ong, Respiratory Technology, Woolcock Institute, Sydney, Australia and Faculty of Heath Sciences, Southampton University

12.10 - Dissolution - A Critical Performance Characteristic of Inhaled Products

Dr. Ben Forbes, Head of the Pharmaceutical Teaching Section and Drug Delivery Research Group of the Pharmaceutical Science Division, Kings College London, UK

12.50 - Discussion

13.00 - Lunch

14.00 u What do Inhaled Nanomedicines Offer?

Professor Sally Ann Cyran, RCSI School of Pharmacy, Royal College of Surgeons, Ireland

14.40 - Electrostatic Properties of Particles for Inhalation

Martin Rowland, Formulation and Process Design Scientist, Pfizer

TECHNOLOGY

15.20 - Device Comparison Based on In Vitro Models

Anna-Maria Ciciliani, Johannes Gutenberg-University Mainz, Germany, Department of Biopharmaceutics and Pharmaceutical Technology on behalf of Boehringer Ingelheim Pharma GmbH & Co. KG, Development, Germany

16.00 - Discussion

16.15 - End of Conference and Tea

For more information visit http://www.researchandmarkets.com/research/btpdfh/inhaled_drug


[ Back To TMCnet.com's Homepage ]